Radiopharm Theranostics Ltd SEC filings RDPTF
Radiopharm Theranostics Ltd has 163 filings in SEC EDGAR's recent list, going back to Dec 16, 2022. Its latest annual report, Form 20-F, was filed on Sep 30, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Nov 4, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 4, 2026 | Nov 4, 2026 |
| 6-K | Current report (foreign issuer) | Oct 30, 2026 | Oct 30, 2026 |
| 4 | Insider transaction | Oct 27, 2026 | Oct 19, 2026 |
| 6-K | Current report (foreign issuer) | Oct 27, 2026 | Oct 27, 2026 |
| 6-K | Current report (foreign issuer) | Oct 26, 2026 | Oct 26, 2026 |
| 6-K | Current report (foreign issuer) | Oct 20, 2026 | Oct 20, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 14, 2026 | — |
| 6-K | Current report (foreign issuer) | Oct 5, 2026 | Oct 5, 2026 |
| 6-K | Current report (foreign issuer) | Oct 1, 2026 | Oct 1, 2026 |
| 20-F | Annual report (foreign issuer) | Sep 30, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| EFFECT | Filing | Sep 23, 2026 | — |
| 424B3 | Prospectus | Sep 23, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 22, 2026 | Sep 22, 2026 |
| 6-K | Current report (foreign issuer) | Sep 14, 2026 | Sep 14, 2026 |
| F-3 | Shelf registration (foreign issuer) | Sep 14, 2026 | — |
| 6-K | Current report (foreign issuer) | Sep 11, 2026 | Sep 11, 2026 |
| 6-K | Current report (foreign issuer) | Sep 9, 2026 | Sep 9, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 4, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Sep 4, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 28, 2026 | Aug 28, 2026 |
| 6-K | Current report (foreign issuer) | Aug 27, 2026 | Aug 27, 2026 |
| 6-K | Current report (foreign issuer) | Aug 26, 2026 | Aug 26, 2026 |
| 6-K | Current report (foreign issuer) | Aug 20, 2026 | Aug 20, 2026 |
| 6-K | Current report (foreign issuer) | Aug 17, 2026 | Aug 17, 2026 |
| 6-K | Current report (foreign issuer) | Aug 13, 2026 | Aug 13, 2026 |
| 6-K | Current report (foreign issuer) | Aug 3, 2026 | Aug 3, 2026 |
| 6-K | Current report (foreign issuer) | Jul 31, 2026 | Jul 31, 2026 |
| 6-K | Current report (foreign issuer) | Jul 28, 2026 | Jul 28, 2026 |
| 6-K | Current report (foreign issuer) | Jul 28, 2026 | Jul 28, 2026 |
| 6-K | Current report (foreign issuer) | Jul 27, 2026 | Jul 27, 2026 |
| 424B5 | Prospectus supplement | Jul 27, 2026 | — |
| 6-K | Current report (foreign issuer) | Jul 24, 2026 | Jul 24, 2026 |
| 424B5 | Prospectus supplement | Jul 23, 2026 | — |
| 6-K | Current report (foreign issuer) | Jul 22, 2026 | Jul 22, 2026 |
| 6-K | Current report (foreign issuer) | Jul 6, 2026 | Jul 3, 2026 |
| 6-K | Current report (foreign issuer) | Jun 30, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jun 3, 2026 | Jun 3, 2026 |
| 3 | Initial insider ownership | May 6, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | May 6, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | May 1, 2026 | May 1, 2026 |
| 3 | Initial insider ownership | Apr 30, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Apr 23, 2026 | Apr 23, 2026 |
| 6-K | Current report (foreign issuer) | Apr 20, 2026 | Apr 20, 2026 |
| 6-K | Current report (foreign issuer) | Apr 16, 2026 | Apr 16, 2026 |
| 6-K | Current report (foreign issuer) | Apr 8, 2026 | Apr 8, 2026 |
| 6-K | Current report (foreign issuer) | Apr 7, 2026 | Apr 7, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 31, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 31, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Mar 27, 2026 | Mar 27, 2026 |
| 6-K | Current report (foreign issuer) | Mar 24, 2026 | Mar 24, 2026 |
| 6-K | Current report (foreign issuer) | Mar 19, 2026 | Mar 19, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Feb 27, 2026 | Feb 27, 2026 |
| 6-K | Current report (foreign issuer) | Feb 24, 2026 | Feb 24, 2026 |
| 6-K | Current report (foreign issuer) | Jan 28, 2026 | Jan 28, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 16, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 12, 2026 | Jan 12, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 8, 2026 | — |
| EFFECT | Filing | Dec 23, 2025 | — |
| EFFECT | Filing | Dec 23, 2025 | — |
| 424B3 | Prospectus | Dec 23, 2025 | — |
| 424B5 | Prospectus supplement | Dec 23, 2025 | — |
| CORRESP | Letter to the SEC | Dec 19, 2025 | — |
| CORRESP | Letter to the SEC | Dec 19, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 19, 2025 | Dec 19, 2025 |
| F-3 | Shelf registration (foreign issuer) | Dec 17, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 16, 2025 | — |
| 6-K | Current report (foreign issuer) | Dec 15, 2025 | Dec 15, 2025 |
| 20-F/A | Amended annual report (foreign issuer) | Dec 10, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Dec 4, 2025 | Dec 3, 2025 |
| 6-K | Current report (foreign issuer) | Nov 25, 2025 | Nov 25, 2025 |
| 6-K | Current report (foreign issuer) | Nov 20, 2025 | Nov 20, 2025 |
| 6-K | Current report (foreign issuer) | Nov 19, 2025 | Nov 19, 2025 |
| 6-K | Current report (foreign issuer) | Nov 18, 2025 | Nov 18, 2025 |
| 6-K | Current report (foreign issuer) | Nov 17, 2025 | Nov 17, 2025 |
| 6-K | Current report (foreign issuer) | Nov 12, 2025 | Nov 12, 2025 |
| 6-K | Current report (foreign issuer) | Nov 4, 2025 | Nov 4, 2025 |
| 6-K | Current report (foreign issuer) | Nov 3, 2025 | Nov 3, 2025 |
| 6-K | Current report (foreign issuer) | Oct 28, 2025 | Oct 28, 2025 |
| 6-K | Current report (foreign issuer) | Oct 23, 2025 | Oct 22, 2025 |
| 6-K | Current report (foreign issuer) | Oct 20, 2025 | Oct 20, 2025 |
| 6-K | Current report (foreign issuer) | Oct 7, 2025 | Oct 7, 2025 |
| 6-K | Current report (foreign issuer) | Oct 1, 2025 | Oct 1, 2025 |
| 6-K | Current report (foreign issuer) | Sep 30, 2025 | Sep 30, 2025 |
| 20-F | Annual report (foreign issuer) | Sep 18, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Sep 17, 2025 | Sep 17, 2025 |
| 6-K | Current report (foreign issuer) | Sep 15, 2025 | Sep 15, 2025 |
| 6-K | Current report (foreign issuer) | Aug 29, 2025 | Aug 29, 2025 |
| 6-K | Current report (foreign issuer) | Aug 21, 2025 | Aug 21, 2025 |
| 6-K | Current report (foreign issuer) | Aug 1, 2025 | Aug 1, 2025 |
| 6-K | Current report (foreign issuer) | Jul 29, 2025 | Jul 29, 2025 |
| 6-K | Current report (foreign issuer) | Jul 28, 2025 | Jul 28, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 23, 2025 | — |
| 6-K | Current report (foreign issuer) | Jul 22, 2025 | Jul 22, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 16, 2025 | — |
| 6-K | Current report (foreign issuer) | Jul 16, 2025 | Jul 16, 2025 |
| 6-K | Current report (foreign issuer) | Jun 24, 2025 | Jun 24, 2025 |
| 6-K | Current report (foreign issuer) | Jun 12, 2025 | Jun 12, 2025 |
| 6-K | Current report (foreign issuer) | Jun 11, 2025 | Jun 11, 2025 |
| 6-K | Current report (foreign issuer) | Jun 4, 2025 | Jun 4, 2025 |
| 6-K | Current report (foreign issuer) | Jun 2, 2025 | Jun 2, 2025 |
| 6-K | Current report (foreign issuer) | May 30, 2025 | May 30, 2025 |
| 6-K | Current report (foreign issuer) | May 19, 2025 | May 19, 2025 |
| 6-K | Current report (foreign issuer) | May 12, 2025 | May 12, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 12, 2025 | — |
| 6-K | Current report (foreign issuer) | Apr 29, 2025 | Apr 29, 2025 |
| 6-K | Current report (foreign issuer) | Apr 28, 2025 | Apr 28, 2025 |
| 6-K | Current report (foreign issuer) | Mar 17, 2025 | Mar 17, 2025 |
| 6-K | Current report (foreign issuer) | Mar 13, 2025 | Mar 13, 2025 |
| 6-K | Current report (foreign issuer) | Mar 7, 2025 | Mar 7, 2025 |
| 6-K | Current report (foreign issuer) | Feb 28, 2025 | Feb 28, 2025 |
| 6-K | Current report (foreign issuer) | Feb 25, 2025 | Feb 25, 2025 |
| 6-K | Current report (foreign issuer) | Feb 24, 2025 | Feb 24, 2025 |
| 6-K | Current report (foreign issuer) | Feb 18, 2025 | Feb 18, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 11, 2025 | — |
| 6-K | Current report (foreign issuer) | Feb 10, 2025 | Feb 10, 2025 |
| 6-K | Current report (foreign issuer) | Jan 30, 2025 | Jan 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 29, 2025 | — |
| 6-K | Current report (foreign issuer) | Jan 21, 2025 | Jan 21, 2025 |
| 6-K | Current report (foreign issuer) | Jan 10, 2025 | Jan 10, 2025 |
| 6-K | Current report (foreign issuer) | Dec 30, 2024 | Dec 30, 2024 |
| 6-K | Current report (foreign issuer) | Dec 20, 2024 | Dec 20, 2024 |
| 6-K | Current report (foreign issuer) | Dec 19, 2024 | Dec 19, 2024 |
| 6-K | Current report (foreign issuer) | Dec 18, 2024 | Dec 18, 2024 |
| EFFECT | Filing | Dec 13, 2024 | — |
| 424B3 | Prospectus | Dec 13, 2024 | — |
| CORRESP | Letter to the SEC | Dec 11, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 10, 2024 | — |
| 6-K | Current report (foreign issuer) | Dec 10, 2024 | Dec 10, 2024 |
| F-1 | Registration statement (foreign issuer) | Dec 5, 2024 | — |
| SEC STAFF LETTER | Filing | Dec 3, 2024 | — |
| F-6/A | Filing | Nov 27, 2024 | — |
| SEC STAFF ACTION | Filing | Nov 27, 2024 | — |
| CERT | Filing | Nov 25, 2024 | — |
| CORRESP | Letter to the SEC | Nov 25, 2024 | — |
| 20FR12B/A | Amendment no. 7 to form 20fr12b | Nov 12, 2024 | — |
| CORRESP | Letter to the SEC | Nov 5, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2024 | — |
| F-6/A | Filing | Oct 25, 2024 | — |
| 20FR12B/A | Amendment no. 6 to form 20fr12b | Oct 21, 2024 | — |
| CORRESP | Letter to the SEC | Sep 25, 2024 | — |
| 20FR12B/A | Amendment no. 5 to form 20fr12b | Sep 25, 2024 | — |
| EFFECT | Filing | Sep 18, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2024 | — |
| F-6 | Filing | Sep 11, 2024 | — |
| CORRESP | Letter to the SEC | Sep 9, 2024 | — |
| 20FR12B/A | Amendment no. 4 to form 20fr12b | Sep 9, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2024 | — |
| 20FR12B/A | Amendment no. 3 to form 20fr12b | Jul 25, 2024 | — |
| CORRESP | Letter to the SEC | Apr 14, 2023 | — |
| 20FR12B/A | Amendment no. 2 to form 20fr12b | Apr 14, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2023 | — |
| CORRESP | Letter to the SEC | Mar 20, 2023 | — |
| 20FR12B/A | Amendment no. 1 to form 20fr12b | Mar 20, 2023 | — |
| SEC STAFF LETTER | Filing | Mar 6, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 1, 2023 | — |
| CORRESP | Letter to the SEC | Feb 13, 2023 | — |
| 20FR12B | Registration statement | Feb 13, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2023 | — |
| DRS | Filing | Dec 16, 2022 | — |
Showing 163 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RADX (Nasdaq), RDPTF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Carlton Vic
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1949257
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.